Acupuncture for Infectious Mononucleosis Trial

Infectious Mononucleosis Clinical Trial

— AIM  

Official title:

Acupuncture for Infectious Mononucleosis Trial

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT00598988
• Other study ID #: 6866
• Status: Terminated
• Phase: Phase 2/Phase 3
• Start date: January 2008
• Est. completion date: December 2008

Study information

• Verified date: May 2017
• Source: University of Alberta
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to investigate feasibility issues related to conducting an acupuncture study in a population of adolescents and young adults with infectious mononucleosis. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Description:

This study examines the feasibility of treating adolescents and young adults diagnosed with infectious mononucleosis with acupuncture. Additionally, this study will provide preliminary data regarding treatment parameters (acupuncture and standard care) and outcomes (i.e. fatigue).

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 3
• Est. completion date: December 2008
• Est. primary completion date: December 2008
• Accepts healthy volunteers: No
• Gender: All
• Age group: 15 Years to 25 Years

Eligibility

Inclusion Criteria:

• mono diagnosis confirmed by lab test

• 21 days or less between start of symptoms and diagnostic test

• presence of fatigue of at least 4/11 (by Chalder Fatigue Questionnaire)

• no other illnesses present

• meets residency requirement

Exclusion Criteria:

• insufficient communication in English

• unable to begin acupuncture within 21 days of diagnostic test

• acupuncture use currently or in the preceding 3 months

• currently under the care of a TCM practitioner

• unwilling to be randomized

Related Conditions & MeSH terms

• Communicable Diseases
• Infections
• Infectious Mononucleosis

Intervention

Procedure:
• traditional Chinese acupuncture
10 treatments over 6 weeks

Other:
• standard medical care
standard care as provided by primary physician

Locations

Country	Name	City	State
Canada	University of Alberta	Edmonton	Alberta

Sponsors (1)

Lead Sponsor	Collaborator
University of Alberta

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Chalder Fatigue Questionnaire		12 weeks
Secondary	MOS SF-36		12 weeks